Search
for
Sort by
Research 151–180 of 416
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- TNF‐inhibitor associated psoriatic alopecia: Diagnostic utility of sebaceous lobule atrophy
- Alopecia associated with quetiapine
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Post-finasteride syndrome
- Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
- Risk of valproic acid-related alopecia: A systematic review and meta-analysis
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Non-hemorrhage-related adverse effects of rivaroxaban
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- Postmarketing Surveillance of New Antiepileptic Drugs: The Tribulations of Trials
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Management of acne vulgaris with hormonal therapies in adult female patients
- Winding the clock back on female androgenetic alopecia
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Pediatric androgenetic alopecia: A review
- Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Post-finasteride syndrome – does it really exist?
- Agent specific effects of anticoagulant induced alopecia
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Finasteride for hair loss: a review
- Acne
- Omeprazole-induced hypertrichosis in two children